Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cheplapharm
Cheplapharm
Takeda to sell another non-core portfolio for $260 million to Cheplapharm
Pharmafile
Tue, 09/8/20 - 10:33 pm
Takeda
Cheplapharm
M&A
AstraZeneca closes deal with Cheplapharm for rights to Seroquel and Seroquel XR in Europe and Russia
Pharmaceutical Business Review
Tue, 12/17/19 - 10:25 am
AstraZeneca
Seroquel
Seroquel XR
Russia
Europe
Cheplapharm
AstraZeneca Sells off Seroquel Rights in U.S. and Canada
BioSpace
Tue, 12/3/19 - 10:44 pm
AstraZeneca
Cheplapharm
Seroquel
Seroquel XR
bipolar disorder
schizophrenia
AstraZeneca to sell anti-psychotic medicine rights in Europe and Russia for $239m
Pharmaceutical Business Review
Thu, 10/31/19 - 10:14 am
AstraZeneca
Seroquel
antipsychotic
Europe
Russia
Cheplapharm
AstraZeneca offloads Atacand in Europe for $200M
Biopharma Dive
Wed, 07/25/18 - 03:13 pm
Atacand
Europe
AstraZeneca
Cheplapharm